Study Stopped
Recruitment problems
Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units
1 other identifier
interventional
160
1 country
1
Brief Summary
Today a variety of diagnostic tools to detect allergenic agents are available such as skin tests, provocation tests and blood tests. Due to its high sensitivity and low costs the skin prick test is the most commonly used test to identify allergies in patients. By using this kind of skin test, up to 25 different agents can be tested in parallel, rendering the skin prick test a cheap, easy-to-handle and rapid diagnostic tool. However, as research proceeds, new tools appear with the intention to make future applications even more convenient -for both, the patient and the physician. For that purpose the development of the so called "Easyprick" Allergen Test System is under way, consisting of a foil that carries ready-to-use, allergen-soaked sponges which can easily be applied to the skin after pricking. Allergen extracts are complex mixtures of proteins and contain varying amounts of allergenic and non-allergenic components. In order to control variability and to achieve consistency and reproducibility for optimal safety and sensitivity/specificity, it is essential to standardize the amount of allergen used in prick tests. The present study aims to standardize eight allergen extracts by using this method. Standardized extracts will then be applied in the Easyprick Allergen Test System which will be evaluated and compared to the conventional prick test in a second study.
- Trial with medicinal product
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Aug 2009
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 28, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedFirst Posted
Study publicly available on registry
August 9, 2011
CompletedAugust 9, 2011
January 1, 2011
1.4 years
April 28, 2010
August 8, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Wheal size
15 minutes after skin prick test with a serial dilution of an allergen extracts, sizes of provoked wheals will be measured according to allergen standardization procedure.
Study Arms (1)
Eight different allergens will be standardized in this study
OTHERInterventions
Eligibility Criteria
You may qualify if:
- years old,
- a positive clinical history for inhalant allergy to at least one of the allergens to be tested,
- at least one positive prick test (mean wheal diameter = 3mm) when tested with already standardized extracts of the allergens under investigation.
- a mean wheal size of = 7mm2 obtained in a prick test with histamine dihydrochloride (10mg/ml).
- Written informed consent
You may not qualify if:
- history of systemic reactions to allergens,
- severe diseases influencing the results of the present study by discretion of the investigator,
- immunotherapy with an allergen preparation known to interfere with the allergens under investigation during the past two years,
- skin lesions in the skin test areas
- pregnancy or nursing,
- treatment with prohibited concomitant medications (antihistamines, corticosteroids, anti-depressants, neuroleptics or specific immunotherapy)
- alcohol or drug abuse,
- impaired in understanding nature, meaning and the scope of the study or are incapable of giving written informed consent,
- Participation in another clinical trial within the last 30 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Trials Center
Zurich, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
01 Studienregister MasterAdmins
UniversitaetsSpital Zuerich
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 28, 2010
First Posted
August 9, 2011
Study Start
August 1, 2009
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
August 9, 2011
Record last verified: 2011-01